...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Right of first refusal
4
Mar 02, 2019 02:31PM
6
Mar 02, 2019 02:59PM
3
Mar 02, 2019 03:16PM
5
Mar 02, 2019 03:40PM
3
Mar 02, 2019 06:29PM
5
Mar 02, 2019 10:31PM
4
Mar 03, 2019 05:31AM
8
Mar 03, 2019 10:48AM
3
Mar 03, 2019 01:43PM
2
Mar 03, 2019 01:50PM
1
Mar 03, 2019 02:50PM
3
Mar 03, 2019 11:18PM
3
Mar 04, 2019 12:07AM
3
Mar 04, 2019 12:47AM
4
Mar 04, 2019 06:10AM
3
Mar 04, 2019 09:56AM
2
Mar 04, 2019 10:29AM
2
Mar 04, 2019 11:53AM
1
Mar 04, 2019 12:19PM
5
Mar 04, 2019 12:45PM
3
Mar 04, 2019 01:06PM
1
Mar 04, 2019 01:22PM
2
Mar 04, 2019 01:24PM

Koo - Yes, I do agree on that but I am saying that with BoM success, a US license on Apabetalone should be worth more than $1 billion. The US market is a huge part of the market and at higher margin than many other areas. I am saying that if it isn't worth more than $1 billion, we will have trouble getting the share price, we are hoping for.

2
Mar 04, 2019 02:07PM
Share
New Message
Please login to post a reply